Sabra Health Care REIT (SBRA): Citi Signs Off On Signature

Citi analyst, Smedes Rose, reiterated his Neutral rating on shares of Sabra Healthcare REIT Inc. (NASDAQ: SBRA) after the company provided an update regarding Signature (6% Net Operating Income) where cash rents have been reduced by $15m to $35m and rents will decline in conjunction with the sale of 4 non-core properties. In conjunction with Omega (OHI), and other interested parties, the analyst believes Signature will essentially be recapitalized.

The analyst stated "We believe full-year FFO guidance at $2.48-2.56 (AFFO $2.28-2.36) incorporates both the $15m reduction at Signature, as well as an additional $1.9m based on asset sales (proceeds expected at $22m, or an implied 8.6% cap rate)".

The company reports 1Q earnings on Wednesday (5/9).

For an analyst ratings summary and ratings history on Sabra Healthcare REIT Inc. click here. For more ratings news on Sabra Healthcare REIT Inc. click here.

Shares of Sabra Healthcare REIT Inc. closed at $19.57 yesterday.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Is the global equity rally broadening? UBS weighs in
• S&P 500 may pull back before midterms, but Citi says buy the dip